Knowledge on the Use of Biosimilars in Hematological Malignancies Amongst Health Care Workers at a Tertiary Hospital in Northeast Nigeria
Background: Hematological malignancies, like other cancers, are on the rise. Their treatments have been revolutionized using biological molecules (biologics and biosimilars). These novel agents are used in the care of cancer patients and have significantly improved survival. While biosimilars are wi...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2024-07-01
|
| Series: | International Journal of Medicine and Health Development |
| Subjects: | |
| Online Access: | https://doi.org/10.4103/ijmh.ijmh_33_23 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832586544811081728 |
|---|---|
| author | Rufai A. Dachi Mustapha S. Umar Maryam Mahdi Nura H. Alkali Falmata G. Mustapha Fatima M. Muhammad Alhaji Abdu |
| author_facet | Rufai A. Dachi Mustapha S. Umar Maryam Mahdi Nura H. Alkali Falmata G. Mustapha Fatima M. Muhammad Alhaji Abdu |
| author_sort | Rufai A. Dachi |
| collection | DOAJ |
| description | Background: Hematological malignancies, like other cancers, are on the rise. Their treatments have been revolutionized using biological molecules (biologics and biosimilars). These novel agents are used in the care of cancer patients and have significantly improved survival. While biosimilars are widely available, their use is still limited in some low- and middle-income countries, including Nigeria. Objectives: To determine the knowledge of healthcare workers (HCWs) at a tertiary hospital in Bauchi, Nigeria, before and after a structured training program on the use of biosimilars in hematological malignancies. Materials and Methods: Healthcare workers underwent a week-long training on biosimilars. Knowledge of pre- and post-training was ascertained using interviewer-administered questionnaires. Participant data was summarized as percentages in charts and tables and compared using the Z-test in Microsoft Excel 2016. P values ≤ 0.05 were considered significant. Results: One hundred and sixty one (161) participants attended the training, with females constituting 56.5%. Participants’ knowledge of cancer and hematological malignancies was significantly higher after training (82.1% vs. 61.5%; Z = 4.12, P < 0.001). One hundred and forty (140) participants participated in the post-test. Similarly, the knowledge of biologics and biosimilars used in hematological malignancies was significantly higher after training (80.0% vs. 44.1%; Z = 6.62, P < 0.001). Conclusion: Knowledge of biosimilars and their use in hematological malignancies was low among HCWs but improved significantly after an educational training program. |
| format | Article |
| id | doaj-art-ee1f1caf1a9749209fa300cd9c36001f |
| institution | Kabale University |
| issn | 2635-3695 2667-2863 |
| language | English |
| publishDate | 2024-07-01 |
| publisher | Wolters Kluwer Medknow Publications |
| record_format | Article |
| series | International Journal of Medicine and Health Development |
| spelling | doaj-art-ee1f1caf1a9749209fa300cd9c36001f2025-01-25T10:09:59ZengWolters Kluwer Medknow PublicationsInternational Journal of Medicine and Health Development2635-36952667-28632024-07-0129325225610.4103/ijmh.ijmh_33_23Knowledge on the Use of Biosimilars in Hematological Malignancies Amongst Health Care Workers at a Tertiary Hospital in Northeast NigeriaRufai A. DachiMustapha S. UmarMaryam MahdiNura H. AlkaliFalmata G. MustaphaFatima M. MuhammadAlhaji AbduBackground: Hematological malignancies, like other cancers, are on the rise. Their treatments have been revolutionized using biological molecules (biologics and biosimilars). These novel agents are used in the care of cancer patients and have significantly improved survival. While biosimilars are widely available, their use is still limited in some low- and middle-income countries, including Nigeria. Objectives: To determine the knowledge of healthcare workers (HCWs) at a tertiary hospital in Bauchi, Nigeria, before and after a structured training program on the use of biosimilars in hematological malignancies. Materials and Methods: Healthcare workers underwent a week-long training on biosimilars. Knowledge of pre- and post-training was ascertained using interviewer-administered questionnaires. Participant data was summarized as percentages in charts and tables and compared using the Z-test in Microsoft Excel 2016. P values ≤ 0.05 were considered significant. Results: One hundred and sixty one (161) participants attended the training, with females constituting 56.5%. Participants’ knowledge of cancer and hematological malignancies was significantly higher after training (82.1% vs. 61.5%; Z = 4.12, P < 0.001). One hundred and forty (140) participants participated in the post-test. Similarly, the knowledge of biologics and biosimilars used in hematological malignancies was significantly higher after training (80.0% vs. 44.1%; Z = 6.62, P < 0.001). Conclusion: Knowledge of biosimilars and their use in hematological malignancies was low among HCWs but improved significantly after an educational training program.https://doi.org/10.4103/ijmh.ijmh_33_23bauchi statebiosimilarshematological malignancieshealthcare workersknowledge |
| spellingShingle | Rufai A. Dachi Mustapha S. Umar Maryam Mahdi Nura H. Alkali Falmata G. Mustapha Fatima M. Muhammad Alhaji Abdu Knowledge on the Use of Biosimilars in Hematological Malignancies Amongst Health Care Workers at a Tertiary Hospital in Northeast Nigeria International Journal of Medicine and Health Development bauchi state biosimilars hematological malignancies healthcare workers knowledge |
| title | Knowledge on the Use of Biosimilars in Hematological Malignancies Amongst Health Care Workers at a Tertiary Hospital in Northeast Nigeria |
| title_full | Knowledge on the Use of Biosimilars in Hematological Malignancies Amongst Health Care Workers at a Tertiary Hospital in Northeast Nigeria |
| title_fullStr | Knowledge on the Use of Biosimilars in Hematological Malignancies Amongst Health Care Workers at a Tertiary Hospital in Northeast Nigeria |
| title_full_unstemmed | Knowledge on the Use of Biosimilars in Hematological Malignancies Amongst Health Care Workers at a Tertiary Hospital in Northeast Nigeria |
| title_short | Knowledge on the Use of Biosimilars in Hematological Malignancies Amongst Health Care Workers at a Tertiary Hospital in Northeast Nigeria |
| title_sort | knowledge on the use of biosimilars in hematological malignancies amongst health care workers at a tertiary hospital in northeast nigeria |
| topic | bauchi state biosimilars hematological malignancies healthcare workers knowledge |
| url | https://doi.org/10.4103/ijmh.ijmh_33_23 |
| work_keys_str_mv | AT rufaiadachi knowledgeontheuseofbiosimilarsinhematologicalmalignanciesamongsthealthcareworkersatatertiaryhospitalinnortheastnigeria AT mustaphasumar knowledgeontheuseofbiosimilarsinhematologicalmalignanciesamongsthealthcareworkersatatertiaryhospitalinnortheastnigeria AT maryammahdi knowledgeontheuseofbiosimilarsinhematologicalmalignanciesamongsthealthcareworkersatatertiaryhospitalinnortheastnigeria AT nurahalkali knowledgeontheuseofbiosimilarsinhematologicalmalignanciesamongsthealthcareworkersatatertiaryhospitalinnortheastnigeria AT falmatagmustapha knowledgeontheuseofbiosimilarsinhematologicalmalignanciesamongsthealthcareworkersatatertiaryhospitalinnortheastnigeria AT fatimammuhammad knowledgeontheuseofbiosimilarsinhematologicalmalignanciesamongsthealthcareworkersatatertiaryhospitalinnortheastnigeria AT alhajiabdu knowledgeontheuseofbiosimilarsinhematologicalmalignanciesamongsthealthcareworkersatatertiaryhospitalinnortheastnigeria |